mCRPC – Talk Bio

Actionable Insights Powered by AI

Lava cuts jobs by 30% after key drug discontinued

LAVA Therapeutics, restructuring, workforce reduction, LAVA-1207, discontinuation, mCRPC, LAVA-1266, strategic alternatives, cash runway